296 related articles for article (PubMed ID: 10393546)
1. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation.
Xu X; Nakano T; Wick S; Dubay M; Brizuela L
Biochemistry; 1999 Jul; 38(27):8713-22. PubMed ID: 10393546
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
5. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes.
Müller D; Bouchard C; Rudolph B; Steiner P; Stuckmann I; Saffrich R; Ansorge W; Huttner W; Eilers M
Oncogene; 1997 Nov; 15(21):2561-76. PubMed ID: 9399644
[TBL] [Abstract][Full Text] [Related]
6. Formation of p27-CDK complexes during the human mitotic cell cycle.
Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A
Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197
[TBL] [Abstract][Full Text] [Related]
7. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
[TBL] [Abstract][Full Text] [Related]
10. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.
Kwon TK; Nordin AA
Oncogene; 1998 Feb; 16(6):755-62. PubMed ID: 9488039
[TBL] [Abstract][Full Text] [Related]
11. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach J; Hennecke S; Alevizopoulos K; Conti D; Amati B
EMBO J; 1996 Dec; 15(23):6595-604. PubMed ID: 8978686
[TBL] [Abstract][Full Text] [Related]
12. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
Taipale M; Tiihonen E; Heiskanen A; Laiho M
Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
[TBL] [Abstract][Full Text] [Related]
16. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
[TBL] [Abstract][Full Text] [Related]
20. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus.
Mann DJ; Child ES; Swanton C; Laman H; Jones N
EMBO J; 1999 Feb; 18(3):654-63. PubMed ID: 9927425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
